$1.6B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | TRVI Trevi Therapeutics Inc | 13.2M | +0.0% | $247M | 15.5% |
| 2 | MBX Mbx Biosciences Inc | 3.6M | +0.0% | $200M | 12.6% |
| 3 | GLUE Monte Rosa Therapeutics Inc | 7.7M | +0.0% | $186M | 11.7% |
| 4 | CELC Celcuity Inc | 1.7M | −25.2% | $179M | 11.3% |
| 5 | SGP Spyglass Pharma Inc | 7.4M | +0.0% | $165M | 10.4% |
| 6 | SVRA Savara Inc | 24.5M | +0.0% | $151M | 9.5% |
| 7 | ZBIO Zenas Biopharma Inc | 4.0M | +0.0% | $102M | 6.4% |
| 8 | COUR Coursera Inc | 12.9M | +0.0% | $73M | 4.6% |
| 9 | AUPH Aurinia Pharmaceuticals Inc | 4.0M | +0.0% | $67M | 4.2% |
| 10 | CRSP Crispr Therapeutics Ag | 1.1M | +0.0% | $58M | 3.6% |
| 11 | ORIC Oric Pharmaceuticals Inc | 4.1M | +0.0% | $45M | 2.8% |
| 12 | PHAT Phathom Pharmaceuticals Inc | 2.0M | +0.0% | $21M | 1.3% |
| 13 | KRRO Korro Bio Inc | 1.3M | +0.0% | $17M | 1.1% |
| 14 | XFOR X4 Pharmaceuticals, Inc. | 3.2M | +0.0% | $15M | 1.0% |
| 15 | CSBR Champions Oncology Inc | 1.7M | +0.0% | $11M | 0.7% |
| 16 | NKTX Nkarta Inc | 3.6M | +0.0% | $10M | 0.6% |
| 17 | CVRX Cvrx Inc | 2.0M | −3.5% | $10M | 0.6% |
| 18 | BDTX Black Diamond Therapeutics I | 4.4M | +0.0% | $8M | 0.5% |
| 19 | KPTIQ Karyopharm Therapeutics Inc | 576,780 | — | $6M | 0.4% |
| 20 | IVA Inventiva Sa | 1.5M | +0.0% | $6M | 0.3% |
| 21 | LONA Leonabio Inc | 464,398 | +0.0% | $4M | 0.3% |
| 22 | SNTI Senti Biosciences, Inc. | 3.8M | +0.0% | $4M | 0.3% |
| 23 | MRKR Marker Therapeutics Inc | 1.6M | +0.0% | $2M | 0.2% |
| 24 | OKUR Onkure Therapeutics Inc | 478,548 | +0.0% | $2M | 0.1% |
| 25 | IMA Imagenebio Inc | 50,005 | +0.0% | $295,030 | 0.0% |
| 26 | GOSS Gossamer Bio Inc | 1.0M | +0.0% | $164,600 | 0.0% |